Original contributionA one-year evaluation of calcium channel blocker overdoses: Toxicity and treatment
References (7)
- et al.
1990 annual report of the American Association of Poison Control Centers national data collection system
Am J Emerg Med
(1991) - et al.
Calcium channel blocker toxicity
Ann Emerg Med
(1990) Comparative pharmacology of calcium antagonists: Nifedipine, verapamil, and diltiazem
Am J Cardiol
(1980)
Cited by (144)
Newly initiated cardiovascular medication and short-term risk of unintentional poisoning among Swedish middle-aged and older adults: A national register-based case-crossover study
2022, Biomedicine and PharmacotherapyCitation Excerpt :Cardiovascular medication is extensively used for the intervention and treatment of cardiometabolic abnormalities and cardiovascular diseases in older adults [1]. The clinical manifestations of cardiovascular medication-induced poisonings include both common adverse drug effects with therapeutic use (e.g., pruritus, rash, diarrhea, dyspnoea, bronchospasm, dizziness, fatigue, mental illness, low/high blood pressure, bradycardia, first-degree heart block) and severe outcomes (e.g., metabolic acidosis, lethargy, syncope, seizures, cardiogenic shock, atrioventricular nodal depression, coma, and death) [2,3]. The population-based studies have shown that cardiovascular medication (e.g., renin-angiotensin system inhibitors, diuretics, beta blockers, calcium-channel blockers, antianginals and antiarrhythmics, centrally acting antiadrenergics, and lipid-lowering agents) is the most common drug category associated with preventable adverse drug events in older adults [4,5].
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society
2019, Journal of the American College of Cardiology2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
2019, Journal of the American College of Cardiology
Presented at the Society for Academic Emergency Medicine Annual Meeting in Washington, DC, May 1991.